FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Erick Schampaert

Research Profile

Disorders

Chemicals & Drugs

Devices

Procedures

Physiology

Platelet Aggregation

Concepts & Ideas

Anatomy

Coronary Vessels

Geographic Areas

Canada

Co-author Network

Publications

TOP 3
Remi Kouz; Simon Kouz; Claude Lauzon; Samer Mansour; Michel Nguyen; Stéphane Rinfret; Erick Schampaert; Jean-Claude Tardif; marc afilalo; Jean-Pierre Dery; Mark Eisenberg; Richard Harvey; thao huynh
Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of observational studies.
Donald A Palisaitis; Sam Radhakrishnan; Suzanne Renner; Jacqueline Saw; Cathy Kells; Michael Love; Rob Welsh; Rod Zimmerman; Erick Schampaert
2010 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiologists Guidelines for Training and Maintenance of Competency in Adult Interventional Cardiology.
Marie Lordkipanidzé; Jean G Diodati; Donald A Palisaitis; Erick Schampaert; Jacques Turgeon; Chantal Pharand
Genetic determinants of response to aspirin: appraisal of 4 candidate genes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Erick Schampaert (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Remi Kouz; Simon Kouz; Claude Lauzon; Samer Mansour; Michel Nguyen; Stéphane Rinfret; Erick Schampaert; Jean-Claude Tardif; marc afilalo; Jean-Pierre Dery; Mark Eisenberg; Richard Harvey; thao huynh
Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of observational studies.
International journal of cardiology 2011;153(3):249-55.
2011: Donald A Palisaitis; Sam Radhakrishnan; Suzanne Renner; Jacqueline Saw; Cathy Kells; Michael Love; Rob Welsh; Rod Zimmerman; Erick Schampaert
2010 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiologists Guidelines for Training and Maintenance of Competency in Adult Interventional Cardiology.
The Canadian journal of cardiology 2011;27(6):865-7.
2011: Marie Lordkipanidzé; Jean G Diodati; Donald A Palisaitis; Erick Schampaert; Jacques Turgeon; Chantal Pharand
Genetic determinants of response to aspirin: appraisal of 4 candidate genes.
Thrombosis research 2011;128(1):47-53.
2011: Marie Lordkipanidzé; Donald A Palisaitis; Chantal Pharand; Erick Schampaert; Jean G Diodati
Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease.
International journal of cardiology 2011;150(1):39-44.
2010: Pallav Garg; David M Charytan; Lena Novack; Donald E Cutlip; Jeffrey J Popma; Jeffrey Moses; Martin B Leon; Joachim Schofer; Guenter Breithardt; Erick Schampaert; Laura Mauri
Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials).
The American journal of cardiology 2010;106(10):1436-42.
2010: Sherif Shousha; Jean G Diodati; Marilyn de Chantal; Thierry Charron; Robert Amyot; Erick Schampaert; Chantal Pharand
Comparison of electrocardiographic recordings in open-chest and closed-chest swine models.
Journal of the American Association for Laboratory Animal Science : JAALAS 2010;49(6):852-5.
2010: Malak El-Rayes; Erick Schampaert; Jean-Claude Tardif; Mark J Eisenberg; marc afilalo; Simon Kouz; Claude Lauzon; Richard Harvey; Michel Nguyen; Remi Kouz; Jean-Pierre Dery; Samer Mansour; Anne-Marie Van Kieu; Stephane Rinfret; thao huynh
Safety and effectiveness of enoxaparin following fibrinolytic therapy: Results of the Acute Myocardial Infarction (AMI)-QUEBEC registry.
The Canadian journal of cardiology 2010;26(8):431-6.
2010: Marie Lordkipanidzé; Jean G Diodati; Jacques Turgeon; Erick Schampaert; Donald A Palisaitis; Chantal Pharand
Platelet count, not oxidative stress, may contribute to inadequate platelet inhibition by aspirin.
International journal of cardiology 2010;143(1):43-50.
2009: Marie Lordkipanidzé; Jean G Diodati; Erick Schampaert; Donald A Palisaitis; Chantal Pharand
Prevalence of unresponsiveness to aspirin and/or clopidogrel in patients with stable coronary heart disease.
The American journal of cardiology 2009;104(9):1189-93.
2009: Marie Lordkipanidzé; Chantal Pharand; Donald A Palisaitis; Erick Schampaert; Jean G Diodati
Insights into the interpretation of light transmission aggregometry for evaluation of platelet aggregation inhibition by clopidogrel.
Thrombosis research 2009;124(5):546-53.
2009: Adriano Caixeta; Martin B Leon; Alexandra J Lansky; Eugenia Nikolsky; Jiro Aoki; Jeffrey W Moses; Joachim Schofer; Marie-Claude Morice; Erick Schampaert; Ajay J Kirtane; Jeffrey J Popma; Helen Parise; Martin Fahy; Roxana Mehran
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Journal of the American College of Cardiology 2009;54(10):894-902.
2009: Marie Lordkipanidzé; Chantal Pharand; Erick Schampaert; Donald A Palisaitis; Jean G Diodati
Evaluation of the platelet count drop method for assessment of platelet function in comparison with "gold standard" light transmission aggregometry.
Thrombosis research 2009;124(4):418-22.
2009: Thuy Anh Nguyen; Marie Lordkipanidzé; Jean G Diodati; Donald A Palisaitis; Erick Schampaert; Jacques Turgeon; Chantal Pharand
Week-long high-maintenance dose clopidogrel regimen achieves better platelet aggregation inhibition than a standard loading dose before percutaneous coronary intervention: results of a double-blind, randomized clinical trial.
Journal of interventional cardiology 2009;22(4):368-77.
2008: Marie Lordkipanidzé; Chantal Pharand; Thuy Anh Nguyen; Erick Schampaert; Donald A Palisaitis; Jean G Diodati
Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients.
European heart journal 2008;29(23):2877-85.
2008: Marie Lordkipanidzé; Chantal Pharand; Thuy Anh Nguyen; Erick Schampaert; Jean G Diodati
Assessment of VerifyNow P2Y12 assay accuracy in evaluating clopidogrel-induced platelet inhibition.
Therapeutic drug monitoring 2008;30(3):372-8.
2008: Eugenia Nikolsky; David R Holmes; Roxana Mehran; George Dangas; Erick Schampaert; Marie-Claude Morice; Joachim Schofer; J Eduardo Sousa; Martin Fahy; Yingbo Na; Dennis J Donohoe; Jeffrey W Moses; Martin B Leon
Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2008;71(7):896-906.
2008: Jean-Claude Tardif; Jean Grégoire; Philippe L L'Allier; Reda Ibrahim; Todd J Anderson; François Reeves; Lawrence M Title; Erick Schampaert; Michel LeMay; Jacques Lespérance; Rob Scott; Marie-Claude Guertin; Marie-Luise Brennan; Stanley L Hazen; Olivier Bertrand
Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial.
Atherosclerosis 2008;197(1):480-6.
2007: Emilia Solinas; Eugenia Nikolsky; Alexandra J Lansky; Ajay J Kirtane; Marie-Claude Morice; Jeffrey J Popma; Joachim Schofer; Erick Schampaert; Tereza Pucelikova; Jiro Aoki; Martin Fahy; George Dangas; Jeffrey W Moses; Donald E Cutlip; Martin B Leon; Roxana Mehran
Gender-specific outcomes after sirolimus-eluting stent implantation.
Journal of the American College of Cardiology 2007;50(22):2111-6.
2007: Marie Lordkipanidzé; Chantal Pharand; Erick Schampaert; Jacques Turgeon; Donald A Palisaitis; Jean G Diodati
A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
European heart journal 2007;28(14):1702-8.
2007: Stéphane Rinfret; Erick Schampaert
Drug-eluting stents.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2007;176(11):1611-2.
2007: Gregg W Stone; Jeffrey W Moses; Stephen G Ellis; Joachim Schofer; Keith D Dawkins; Marie-Claude Morice; Antonio Colombo; Erick Schampaert; Eberhard Grube; Ajay J Kirtane; Donald E Cutlip; Martin Fahy; Stuart J Pocock; Roxana Mehran; Martin B Leon
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
The New England journal of medicine 2007;356(10):998-1008.
2007: Machael P Love; Erick Schampaert; Eric A Cohen; John G Webb; Todd J Anderson; Marino Labinaz; Jean-François Tanguay; Vladimír Dzavík
The Canadian Association of Interventional Cardiology and the Canadian Cardiovascular Society joint statement on drug-eluting stents.
The Canadian journal of cardiology 2007;23(2):121-3.
2006: thao huynh; Jennifer O'Loughlin; Lawrence Joseph; Erick Schampaert; Stéphane Rinfret; marc afilalo; Simon Kouz; Bernard Cantin; Michel Nguyen; Mark J Eisenberg
Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2006;175(12):1527-32.
2006: David R Holmes; Jeffrey W Moses; Joachim Schofer; Marie-Claude Morice; Erick Schampaert; Martin B Leon
Cause of death with bare metal and sirolimus-eluting stents.
European heart journal 2006;27(23):2815-22.
2006: Marilyn de Chantal; Jean G Diodati; James B Nasmith; Robert Amyot; A-Robert LeBlanc; Erick Schampaert; Chantal Pharand
Progressive epicardial coronary blood flow reduction fails to produce ST-segment depression at normal heart rates.
American journal of physiology. Heart and circulatory physiology 2006;291(6):H2889-96.
2006: Dean J Kereiakes; Hong Wang; Jeffrey J Popma; Richard E Kuntz; Dennis J Donohoe; Joachim Schofer; Erick Schampaert; Bernhard Meier; Martin B Leon; Jeffrey W Moses
Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials.
Journal of the American College of Cardiology 2006;48(1):21-31.
2006: Erick Schampaert; Jeffrey W Moses; Joachim Schofer; Michael Schlüter; Anthony H Gershlick; Eric A Cohen; Donald A Palisaitis; Günter Breithardt; Dennis J Donohoe; Hong Wang; Jeffrey J Popma; Richard E Kuntz; Martin B Leon
Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses.
The American journal of cardiology 2006;98(1):36-41.
2006: Stéphane Rinfret; David J Cohen; Amir A Tahami Monfared; Jacques LeLorier; Jean Mireault; Erick Schampaert
Cost effectiveness of the sirolimus-eluting stent in high-risk patients in Canada: an analysis from the C-SIRIUS trial.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2006;6(3):159-68.
2005: Matthieu Boucher; Boubacar Pasto Wann; Sévan KALOUSTIAN; Rachel Massé; Erick Schampaert; René Cardinal; Guy Rousseau
Sustained cardioprotection afforded by A2A adenosine receptor stimulation after 72 hours of myocardial reperfusion.
Journal of cardiovascular pharmacology 2005;45(5):439-46.
2005: Michael Schlüter; Joachim Schofer; Anthony H Gershlick; Erick Schampaert; William Wijns; Günter Breithardt
Direct stenting of native de novo coronary artery lesions with the sirolimus-eluting stent: a post hoc subanalysis of the pooled E- and C-SIRIUS trials.
Journal of the American College of Cardiology 2005;45(1):10-3.
2004: Jean-Claude Tardif; Jean Grégoire; Philippe L L'Allier; Todd J Anderson; Olivier Bertrand; François Reeves; Lawrence M Title; Fernando Alfonso; Erick Schampaert; Alita Hassan; Richard McLain; Milton L Pressler; Reda Ibrahim; Jacques Lespérance; John Blue; Therese Heinonen; Josep Rodés-Cabau
Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions.
Circulation 2004;110(21):3372-7.
2004: Erick Schampaert; Eric A Cohen; Michael Schlüter; François Reeves; Mouhieddin Traboulsi; Lawrence M Title; Richard E Kuntz; Jeffrey J Popma
The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).
Journal of the American College of Cardiology 2004;43(6):1110-5.
2004: Matthieu Boucher; Stéphanie Pesant; Stéphanie Falcao; Chantal de Montigny; Erick Schampaert; René Cardinal; Guy Rousseau
Post-ischemic cardioprotection by A2A adenosine receptors: dependent of phosphatidylinositol 3-kinase pathway.
Journal of cardiovascular pharmacology 2004;43(3):416-22.
2003: Joachim Schofer; Michael Schlüter; Anthony H Gershlick; William Wijns; Eulogio Garcia; Erick Schampaert; Günter Breithardt
Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).
Lancet 2003;362(9390):1093-9.